Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

Haematologica, 2000 - haematologica.org
BACKGROUND AND OBJECTIVES: Recent progress in the development of diagnostic
techniques has greatly facilitated the monitoring of minimal residual disease (MRD) in …
被引用次数：40 相关文章

Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

J Román, MA Alvarez, A Torres - Haematologica, 2000 - pubmed.ncbi.nlm.nih.gov
Background and objectives Recent progress in the development of diagnostic techniques
has greatly facilitated the monitoring of minimal residual disease (MRD) in patients with …

[引用][C] Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

J ROMAN - Haematologica, 2000 - cir.nii.ac.jp
Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after
allogeneic bone marrow transplantation | CiNii Research CiNii 国立情報学研究所 学術情報 …

Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

J Roman, MA Alvarez, A Torres - Haematologica, 2000 - haematologica.org
BACKGROUND AND OBJECTIVES: Recent progress in the development of diagnostic
techniques has greatly facilitated the monitoring of minimal residual disease (MRD) in …

[引用][C] Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

J ROMAN, MA ALVAREZ… - Haematologica (Roma), 2000 - pascal-francis.inist.fr
Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after
allogeneic bone marrow transplantation CNRS Inist Pascal-Francis CNRS Pascal and …

[引用][C] Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

J ROMAN, MA ALVAREZ, A TORRES - Haematologica, 2000 - Ferrata Storti Foundation